Promoted Content
Promoted Content

Overview of Tamoxifen Citrate

Client Email Product
Tamoxifen Citrate
  • Synopsis

  • Chemistry

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
391

API Market Place

INTERMEDIATES
DOSSIERs
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

Dossiers Market Place

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

MEDIA

Blog

News

REFERENCE STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

0

SERVICES

0

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: It provides solubility and viscosity stability on strong high viscosity.
Dosage Form: Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
Technical Specifications: Strong High Viscosity

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: It provides smooth solutions, based on uniform substitution with low viscosity.
Dosage Form: Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
Technical Specifications: Low Viscosity

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: It provides solubility and viscosity stability on medium viscosity.
Dosage Form: Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
Technical Specifications: Medium Viscosity

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: It is used in film coating of tablets due to its higher molecular weight and higher resistance to simulated gastric fluid, high degree of polymerisation.
Ingredient(s): Hypromellose
Dosage Form: Tablet
More Info on Category: Coating Systems & Additives
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- Ph.Eur, USP/NF, JP/JPE
Technical Specifications: Also Available as Microlex® HML C2906, Microlex® HML C2208.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: It is also suitable for both wet granulation and direct compression methods of tablet production. Microlex® crystalline grades are used in wet granulation and the spray dried forms are used in direct compression.
Ingredient(s): Anhydrous Lactose
Dosage Form: Tablet
More Info on Category: Direct Compression, Granulation
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
Technical Specifications: Milled; Also Available as Microlex® LCA 120.m, Microlex® LCA 200.m

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: It is also suitable for both wet granulation and direct compression methods of tablet production. Microlex® crystalline grades are used in wet granulation and the spray dried forms are used in direct compression.
Ingredient(s): Lactose Monohydrate
Dosage Form: Tablet
More Info on Category: Direct Compression, Granulation
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
Technical Specifications: Sieved; Also Available as Microlex® LCM 180.s, Microlex® LCM 220.s

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: Lactose monohydrate is typically used for wet or dry granulation. During wet granulation, liquid binders or adhesives are added to the lactose and active mixture, usually by blending.
Ingredient(s): Lactose Monohydrate
Dosage Form: Tablet
More Info on Category: Direct Compression, Granulation
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
Technical Specifications: Milled; Also Available as Microlex® LCM 180.m, Microlex® LCM 200.m

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: Tablets made from these granules are typically easily disintegrated using conventional super disintegrates even when hard tablets are compressed.
Dosage Form: Tablet
More Info on Category: Direct Compression, Granulation
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
Technical Specifications: Not Available

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: The plastic defamation characteristics of  MCC 102 type mean that very hard tablets can be produced at light compaction forces, extending tooling lifetime and solving problems with poorly compressible actives.
Dosage Form: Tablet
More Info on Category: Direct Compression
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE
Technical Specifications: Not Available

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Contact the Supplier
Applications: It is used as Diurectic-osmotic for injectable solution, Dialysis solution, Injectible and Parenteral solution.
Ingredient(s): Mannitol
More Info on Category: Parenteral
Route of Administration (Grade): Parenteral
Pharmacopoeia Reference: Monograph- Ph.Eur, USP/NF, JP/JPE, FDA IIG
Technical Specifications: Not Available
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
left grey arrow
right gray arrow
  • TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
  • TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty

Advertise With Us

Advertise With Us